Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 50

1.

Heart rate variability as a biomarker for epilepsy seizure prediction.

Moridani MK, Farhadi H.

Bratisl Lek Listy. 2017;118(1):3-8. doi: 10.4149/BLL_2017_001.

PMID:
28127975
2.

WITHDRAWN: Mortality risk prediction for cardiovascular patients using of artificial neural networks.

Moridani MK, Setarehdan SK, Nasrabadi AM, Hajinasrollah E.

Technol Health Care. 2015 Aug 7. [Epub ahead of print]

PMID:
26409510
3.

New algorithm of mortality risk prediction for cardiovascular patients admitted in intensive care unit.

Moridani MK, Setarehdan SK, Nasrabadi AM, Hajinasrollah E.

Int J Clin Exp Med. 2015 Jun 15;8(6):8916-26. eCollection 2015.

4.

Non-linear Poincaré analysis of respiratory efforts in sleep apnea.

Behbahani S, Moridani MK.

Bratisl Lek Listy. 2015;116(7):426-32.

PMID:
26286245
5.

Bioactivation of luteolin by tyrosinase selectively inhibits glutathione S-transferase.

Balyan R, Kudugunti SK, Hamad HA, Yousef MS, Moridani MY.

Chem Biol Interact. 2015 Oct 5;240:208-18. doi: 10.1016/j.cbi.2015.08.011. Epub 2015 Aug 14.

PMID:
26279214
6.

Drug development and discovery: challenges and opportunities.

Moridani M, Harirforoosh S.

Drug Discov Today. 2014 Nov;19(11):1679-1681. doi: 10.1016/j.drudis.2014.06.003. Epub 2014 Jun 10. No abstract available.

PMID:
24928030
7.

Oxidative stress in aging.

Abdollahi M, Moridani MY, Aruoma OI, Mostafalou S.

Oxid Med Cell Longev. 2014;2014:876834. doi: 10.1155/2014/876834. Epub 2014 Apr 6. No abstract available.

8.

Cefoxitin continuous infusion for lung infection caused by the Mycobacterium abscessus group.

Czaja CA, Levin A, Moridani M, Krank JL, Curran-Everett D, Anderson PL.

Antimicrob Agents Chemother. 2014 Jun;58(6):3570-1. doi: 10.1128/AAC.02763-14. Epub 2014 Apr 14. No abstract available.

9.

Efficacy of acetylsalicylic acid (aspirin) in skin B16-F0 melanoma tumor-bearing C57BL/6 mice.

Vad NM, Kudugunti SK, Wang H, Bhat GJ, Moridani MY.

Tumour Biol. 2014 May;35(5):4967-76. doi: 10.1007/s13277-014-1654-1. Epub 2014 Feb 4.

PMID:
24492939
10.

Caffeic acid phenethyl ester suppresses melanoma tumor growth by inhibiting PI3K/AKT/XIAP pathway.

Pramanik KC, Kudugunti SK, Fofaria NM, Moridani MY, Srivastava SK.

Carcinogenesis. 2013 Sep;34(9):2061-70. doi: 10.1093/carcin/bgt154. Epub 2013 May 2.

11.

Lookalike, soundalike tests: preventing serious medical errors.

Moridani M, Scott T.

Arch Pathol Lab Med. 2013 Jan;137(1):11. doi: 10.5858/arpa.2012-0147-LE. No abstract available.

PMID:
23276168
12.

Renoprotective effects of (+)-catechin in streptozotocin-induced diabetic rat model.

Chennasamudram SP, Kudugunti S, Boreddy PR, Moridani MY, Vasylyeva TL.

Nutr Res. 2012 May;32(5):347-56. doi: 10.1016/j.nutres.2012.03.015. Epub 2012 May 15.

PMID:
22652374
13.

Luteolin induces apoptosis in multidrug resistant cancer cells without affecting the drug transporter function: involvement of cell line-specific apoptotic mechanisms.

Rao PS, Satelli A, Moridani M, Jenkins M, Rao US.

Int J Cancer. 2012 Jun 1;130(11):2703-14. doi: 10.1002/ijc.26308. Epub 2011 Aug 25.

14.

Aspirin acetylates multiple cellular proteins in HCT-116 colon cancer cells: Identification of novel targets.

Marimuthu S, Chivukula RS, Alfonso LF, Moridani M, Hagen FK, Bhat GJ.

Int J Oncol. 2011 Nov;39(5):1273-83. doi: 10.3892/ijo.2011.1113. Epub 2011 Jul 4.

PMID:
21743961
15.

The metabolic bioactivation of caffeic acid phenethyl ester (CAPE) mediated by tyrosinase selectively inhibits glutathione S-transferase.

Kudugunti SK, Thorsheim H, Yousef MS, Guan L, Moridani MY.

Chem Biol Interact. 2011 Jul 15;192(3):243-56. doi: 10.1016/j.cbi.2011.03.015. Epub 2011 Mar 31.

16.

Biochemical mechanism of caffeic acid phenylethyl ester (CAPE) selective toxicity towards melanoma cell lines.

Kudugunti SK, Vad NM, Whiteside AJ, Naik BU, Yusuf MA, Srivenugopal KS, Moridani MY.

Chem Biol Interact. 2010 Oct 6;188(1):1-14. doi: 10.1016/j.cbi.2010.05.018. Epub 2010 Jun 4.

17.

Structure-toxicity relationship of phenolic analogs as anti-melanoma agents: an enzyme directed prodrug approach.

Vad NM, Kandala PK, Srivastava SK, Moridani MY.

Chem Biol Interact. 2010 Feb 12;183(3):462-71. doi: 10.1016/j.cbi.2009.11.020. Epub 2009 Nov 26.

18.

The importance of including topics related to pharmacogenetics, pharmacogenomics, and medical genetics in the pharmacy curriculum.

Harirforoosh S, Fleckenstein L, Mahajan P, Aruoma OI, Huang Y, Moridani M.

Am J Pharm Educ. 2009 Oct 1;73(6):114. No abstract available.

19.

Efficacy of caffeic acid phenethyl ester (CAPE) in skin B16-F0 melanoma tumor bearing C57BL/6 mice.

Kudugunti SK, Vad NM, Ekogbo E, Moridani MY.

Invest New Drugs. 2011 Feb;29(1):52-62. doi: 10.1007/s10637-009-9334-5. Epub 2009 Oct 21.

PMID:
19844662
20.

Interindividual variations in the efficacy and toxicity of vaccines.

Thomas C, Moridani M.

Toxicology. 2010 Dec 5;278(2):204-10. doi: 10.1016/j.tox.2009.10.008. Epub 2009 Oct 28. Review.

PMID:
19837123
21.

Efficacy of acetaminophen in skin B16-F0 melanoma tumor-bearing C57BL/6 mice.

Vad NM, Kudugunti SK, Graber D, Bailey N, Srivenugopal K, Moridani MY.

Int J Oncol. 2009 Jul;35(1):193-204.

PMID:
19513568
22.

AAPS-FIP summary workshop report: Pharmacogenetics in individualized medicine: methods, regulatory, and clinical applications.

Moridani M, Maitland-van der Zee AH, Sasaki H, McKinnon R, Fleckenstein L, Shah VP.

AAPS J. 2009 Jun;11(2):214-6. doi: 10.1208/s12248-009-9097-0. Epub 2009 Mar 25.

23.

Biochemical mechanism of acetylsalicylic acid (Aspirin) selective toxicity toward melanoma cell lines.

Vad NM, Yount G, Moridani MY.

Melanoma Res. 2008 Dec;18(6):386-99. doi: 10.1097/CMR.0b013e3283107df7.

PMID:
18971789
24.

Biochemical mechanism of acetaminophen (APAP) induced toxicity in melanoma cell lines.

Vad NM, Yount G, Moore D, Weidanz J, Moridani MY.

J Pharm Sci. 2009 Apr;98(4):1409-25. doi: 10.1002/jps.21505.

25.

Metabolic bioactivation and toxicity of ethyl 4-hydroxybenzoate in human SK-MEL-28 melanoma cells.

Vad NM, Shaik IH, Mehvar R, Moridani MY.

J Pharm Sci. 2008 May;97(5):1934-45.

PMID:
17847068
27.

Frequency of CYP2C9 polymorphisms affecting warfarin metabolism in a large anticoagulant clinic cohort.

Moridani M, Fu L, Selby R, Yun F, Sukovic T, Wong B, Cole DE.

Clin Biochem. 2006 Jun;39(6):606-12. Epub 2006 Apr 21.

PMID:
16630605
28.

Biochemical basis of 4-hydroxyanisole induced cell toxicity towards B16-F0 melanoma cells.

Moridani MY.

Cancer Lett. 2006 Nov 18;243(2):235-45. Epub 2006 Jan 19.

PMID:
16427188
29.

Structural toxicity relationship of 4-alkoxyphenols' cytotoxicity towards murine B16-F0 melanoma cell line.

Moridani MY, Moore M, Bartsch RA, Yang Y, Heibati-Sadati S.

J Pharm Pharm Sci. 2005 Aug 18;8(2):348-60.

30.

Molecular cytotoxic mechanisms of anticancer hydroxychalcones.

Sabzevari O, Galati G, Moridani MY, Siraki A, O'Brien PJ.

Chem Biol Interact. 2004 Jun 30;148(1-2):57-67.

PMID:
15223357
31.

Quantitative structure toxicity relationships for catechols in isolated rat hepatocytes.

Moridani MY, Siraki A, Chevaldina T, Scobie H, O'Brien PJ.

Chem Biol Interact. 2004 Apr 15;147(3):297-307.

PMID:
15135085
32.

Unexpected relationship between plasma homocysteine and intrauterine growth restriction.

Moridani MY.

Clin Chem. 2004 Apr;50(4):782-4; author reply 784-5. No abstract available.

PMID:
15044347
33.

Quantitative structure-toxicity relationships by accelerated cytotoxicity mechanism screening.

Siraki AG, Chevaldina T, Moridani MY, O'Brien PJ.

Curr Opin Drug Discov Devel. 2004 Jan;7(1):118-25. Review.

PMID:
14982155
35.

Quantitative structure toxicity relationships for phenols in isolated rat hepatocytes.

Moridani MY, Siraki A, O'Brien PJ.

Chem Biol Interact. 2003 May 6;145(2):213-23.

PMID:
12686497
36.
37.

Dietary flavonoid iron complexes as cytoprotective superoxide radical scavengers.

Moridani MY, Pourahmad J, Bui H, Siraki A, O'Brien PJ.

Free Radic Biol Med. 2003 Jan 15;34(2):243-53.

PMID:
12521606
38.

Metabolic activation of 3-hydroxyanisole by isolated rat hepatocytes.

Moridani MY, Cheon SS, Khan S, O'Brien PJ.

Chem Biol Interact. 2003 Jan 6;142(3):317-33.

PMID:
12453669
39.

Metabolic activation of 4-hydroxyanisole by isolated rat hepatocytes.

Moridani MY, Cheon SS, Khan S, O'Brien PJ.

Drug Metab Dispos. 2002 Oct;30(10):1063-9.

40.

Metabolism of caffeic acid by isolated rat hepatocytes and subcellular fractions.

Moridani MY, Scobie H, O'Brien PJ.

Toxicol Lett. 2002 Jul 21;133(2-3):141-51.

PMID:
12119122
41.

Synthesis and physicochemical assessment of novel 2-substituted 3-hydroxypyridin-4-ones, novel iron chelators.

Moridani MY, Tilbrook GS, Khodr HH, Hider RC.

J Pharm Pharmacol. 2002 Mar;54(3):349-64.

PMID:
11902801
42.
43.

Hydrogen peroxide supports hepatocyte P450 catalysed xenobiotic/drug metabolic activation to form cytotoxic reactive intermediates.

Chan TS, Moridani M, Siraki A, Scobie H, Beard K, Eghbal MA, Galati G, O'Brien PJ.

Adv Exp Med Biol. 2001;500:233-6.

PMID:
11764944
44.

Iron complexes of deferiprone and dietary plant catechols as cytoprotective superoxide radical scavengers(1).

Moridani MY, O'Brien PJ.

Biochem Pharmacol. 2001 Dec 15;62(12):1579-85.

PMID:
11755110
45.

Caffeic acid, chlorogenic acid, and dihydrocaffeic acid metabolism: glutathione conjugate formation.

Moridani MY, Scobie H, Jamshidzadeh A, Salehi P, O'Brien PJ.

Drug Metab Dispos. 2001 Nov;29(11):1432-9.

46.

Catechin metabolism: glutathione conjugate formation catalyzed by tyrosinase, peroxidase, and cytochrome p450.

Moridani MY, Scobie H, Salehi P, O'Brien PJ.

Chem Res Toxicol. 2001 Jul;14(7):841-8.

PMID:
11453730
47.

Cytochrome P450 2E1 metabolically activates propargyl alcohol: propiolaldehyde-induced hepatocyte cytotoxicity.

Moridani MY, Khan S, Chan T, Teng S, Beard K, O'Brien PJ.

Chem Biol Interact. 2001 Jan 30;130-132(1-3):931-42.

PMID:
11306107
48.

The formaldehyde metabolic detoxification enzyme systems and molecular cytotoxic mechanism in isolated rat hepatocytes.

Teng S, Beard K, Pourahmad J, Moridani M, Easson E, Poon R, O'Brien PJ.

Chem Biol Interact. 2001 Jan 30;130-132(1-3):285-96.

PMID:
11306052
49.

Cancer chemoprevention and apoptosis mechanisms induced by dietary polyphenolics.

Galati G, Teng S, Moridani MY, Chan TS, O'Brien PJ.

Drug Metabol Drug Interact. 2000;17(1-4):311-49.

PMID:
11201302
50.

Peroxidative metabolism of apigenin and naringenin versus luteolin and quercetin: glutathione oxidation and conjugation.

Galati G, Moridani MY, Chan TS, O'Brien PJ.

Free Radic Biol Med. 2001 Feb 15;30(4):370-82.

PMID:
11182292

Supplemental Content

Loading ...
Support Center